Source: Virtual Congress 2021 – Scientific year in review



Rating:

Share or cite this content

Citations should be made in the following way:
M. Cavaleri (Amsterdam, Netherlands). COVID-19 mRNA vaccines: a step forward from traditional vaccines?. Virtual Congress 2021 – Scientific year in review

Member's Comments

No comment yet.

Related content which might interest you: Development of RSV vaccines: where are we? Source: International Congress 2019 – Respiratory syncytial virus infections throughout life Year: 2019 COVID-19 vaccines: immunology, regulation and clinical management Source: Eur Respir Monogr 2021; 94: 244-260 Year: 2021 Novel intradermal influenza vaccine: phase 3 data in targeted adult populations Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care Year: 2008 Is our approach to basic research right? Pitfalls and successes: what is the way forward? Source: ERS Research Seminar 2016 Year: 2016 Application of management guidelines to the assessment of new medicines: driving us forward or holding us back? Source: Eur Respir J 2004; 23: 793-794 Year: 2004 The new era of diagnostics: will it ever start? Source: International Congress 2019 – Fighting antimicrobial resistance: from prevention to antimicrobial stewardship Year: 2019 New treatments for RSV and other viruses, including update on vaccines Source: ERS Courses: Paediatric respiratory infections Year: 2019 Immunology underpinning vaccine strategy: what is the risk of reinfection? Source: Virtual Congress 2020 – Management prevention Year: 2020 Targeting targeted therapies: more choices and the best sequences Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer Year: 2018 Tuberculosis diagnostics: which target product profiles should be prioritised? Source: Eur Respir J 2014; 44: 537-540 Year: 2014 Pneumococcal vaccine: when, what, how and to whom Source: International Congress 2014 – MS06 What's new in pneumococcal vaccination? Year: 2014 Drug repurposing and other strategies for rapid coronavirus antiviral development: lessons from the early stage of the COVID-19 pandemic Source: Eur Respir Monogr 2021; 94: 39-68 Year: 2021 Ebola: progress with vaccines Source: International Congress 2015 – Pandemics and emerging infections Year: 2015 Development of RSV antiviral treatment: where are we? Source: International Congress 2019 – Respiratory syncytial virus infections throughout life Year: 2019 How to stop LC-fILD progression: an overview of modern therapeutic strategies Source: Virtual Congress 2021 – Lung cancer and fibrotic interstitial lung diseases: a challenging association for pulmonologists Year: 2021 Influenza surveillance and vaccination: new developments Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice Year: 2017 The present and the future of vaccines and other preventive measures in the era of EID Source: Postgraduate course 2021: PG7 - Postgraduate course : Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions Year: 2021